Newmont shorts build after earnings miss
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
NEM short interest jumped 12% in one week to 18.1 million shares, or 1.66% of free float, as of October 26. That reverses a month-long decline and marks the sharpest weekly build since September.
The timing follows the Q3 earnings release on October 22. The stock fell 7.1% on the day of the print. It has now lost 6.5% over the past week, broadly in line with the peer group median of -6.7%, with AEM, AU, and WPM all down 6 to 8% over the same period.
Analyst reactions diverge
Freedom Broker downgraded NEM from Buy to Hold on October 22, cutting its target 11% from $130 to $116. That brings the new target roughly in line with where the stock is trading now at $110.39.
The move contrasts with actions taken just before the print. Citigroup raised its target from $125 to $140 on October 20, maintaining its Buy. Barclays trimmed its Overweight target fractionally to $123 on October 19. Both of those targets now sit materially above the current price. The Street mean target stands at $135.60, implying roughly 23% upside from current levels.
RBC Capital holds the most optimistic target at $155 with an Outperform. Bernstein sits at $144, also Outperform. No firm has pulled a positive rating since the print.
Borrow cost and availability
Cost to borrow rose 31% over the past week to 0.45% as of October 26, with an intraday reading of 0.75% seen on October 22, the day of the earnings release. The move is notable in the context of an otherwise loose lending market. Availability remains effectively uncapped at the 9,999% ceiling, with over one billion shares available to lend. At 1.66% of float, short interest is low by any measure. The borrow cost rise reflects an increase in demand, not a shortage of supply.
What the data shows
- Short interest: 18.1 million shares, 1.66% of free float, up 12% in one week
- Short interest one month ago: roughly flat, up 0.6% over 30 days
- Cost to borrow: 0.45% as of October 26, up 31% over one week
- Share price: $110.39, down 6.5% over the past week, down 9.1% over the past month
- Street mean price target: $135.60 across recent analyst coverage
- Freedom Broker target: $116, the only post-earnings downgrade on record
- Availability: above 1 billion shares lendable, borrow market effectively unconstrained
- Options put/call ratio: 0.78, a z-score of 0.29 against the 20-day mean, near the middle of the past year's range
Stocks in this article
See the live data behind this article on ORTEX.
Open NEM on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 11:15
- Data as of
- 27 Oct 2026, 11:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.